The net profit of “Tchaikapharma High-Quality Medicines” AD for 2025 amounts to €3,075,294.29. The General Meeting of Shareholders, scheduled for June 24, will decide on its distribution.   The Board of Directors proposes that 10% of the net profit be allocated to a mandatory reserve (€307,529.43) and €13,764.86 to additional reserves.   The pharmaceutical company’s […]

Tchaikapharma High Quality Medicines is one of the fastest-growing Bulgarian pharmaceutical companies, producing generic medicinal products. Its revenues at the end of the third quarter amounted to BGN 47.94 million, compared to BGN 40.41 million a year earlier. The company’s net profit reached BGN 6.6 million, marking an annual increase of 51.89%, according to the figures […]

Tchaikapharma High Quality Medicines reported a 19.61% increase in sales revenue for the first half of the year, reaching BGN 32.11 million. Net profit as of the end of June stood at BGN 4.78 million, up from BGN 2.81 million in the same period last year, according to the company’s financial report for the second […]

Therapeutic solutions ensure good control of cardiovascular diseases and increase patients’ quality of life   According to the data of the National Health Insurance Fund for the third quarter of the last year, Tchaikapharma’s medicinal product “Zornichka” with active ingredient (INN) chlorthalidone marked an increase in the number of packages sold by nearly 95% (compared […]

Once again, Tchaikapharma High Quality Medicines participated in the National Conference on Hospital Pharmacy held in Sofia from 18-20 October 2024. The leading Bulgarian manufacturer of complex generics (polypills) presented its new products for the treatment of socially significant diseases such as cerebrovascular disease, Parkinson’s disease, impaired metabolic syndrome, angina pectoris, arterial hypertension and heart […]